Analysts: Abiomed Inc (ABMD.OQ)

ABMD.OQ on NASDAQ Stock Exchange Global Select Market

24.15USD
1 Aug 2013
Price Change (% chg)

$-0.93 (-3.71%)
Prev Close
$25.08
Open
$25.22
Day's High
$25.22
Day's Low
$22.94
Volume
422,319
Avg. Vol
118,161
52-wk High
$25.24
52-wk Low
$11.82

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.07 March 1 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 4 4
(2) OUTPERFORM 2 2 2 2
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 2 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.40 2.40 2.27 2.27

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 7 44.10 45.40 43.00 44.95
Quarter Ending Dec-13 7 45.99 47.50 43.60 46.95
Year Ending Mar-13 11 156.34 158.14 155.10 --
Year Ending Mar-14 10 183.79 188.00 180.82 184.62
Year Ending Mar-15 8 208.82 223.54 184.50 218.60
Earnings (per share)
Quarter Ending Sep-13 9 0.07 0.11 0.05 0.12
Quarter Ending Dec-13 9 0.08 0.11 0.06 0.16
Year Ending Mar-13 12 0.35 0.37 0.32 --
Year Ending Mar-14 9 0.32 0.44 0.27 0.44
Year Ending Mar-15 7 0.59 0.88 0.49 0.89
LT Growth Rate (%) 2 37.50 55.00 20.00 25.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 41.95 43.67 1.72 4.11
Quarter Ending Dec-12 38.04 38.25 0.21 0.54
Quarter Ending Sep-12 37.47 37.42 0.05 0.14
Quarter Ending Jun-12 36.88 38.78 1.91 5.17
Quarter Ending Mar-12 34.92 37.34 2.42 6.93
Earnings (per share)
Quarter Ending Mar-13 0.07 0.09 0.02 22.28
Quarter Ending Dec-12 0.07 0.07 0.00 2.94
Quarter Ending Sep-12 0.05 0.13 0.08 141.64
Quarter Ending Jun-12 0.03 0.08 0.05 166.67
Quarter Ending Mar-12 0.06 0.06 0.00 2.28

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 44.10 44.10 44.10 44.10 44.95
Quarter Ending Dec-13 45.99 45.99 45.99 45.99 46.95
Year Ending Mar-13 156.34 -- -- -- --
Year Ending Mar-14 183.79 183.79 183.79 183.81 184.62
Year Ending Mar-15 208.82 208.82 208.82 208.82 218.60
Earnings (per share)
Quarter Ending Sep-13 0.07 0.07 0.08 0.07 0.12
Quarter Ending Dec-13 0.08 0.08 0.08 0.08 0.16
Quarter Ending Mar-13 0.35 -- -- -- --
Quarter Ending Mar-14 0.32 0.32 0.32 0.32 0.44
Quarter Ending Mar-15 0.59 0.59 0.59 0.60 0.89

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Mar-13 -- -- -- --
Year Ending Mar-14 0 0 0 0
Year Ending Mar-15 0 0 0 0
Earnings
Quarter Ending Sep-13 0 0 0 1
Quarter Ending Dec-13 0 0 0 1
Year Ending Mar-13 -- -- -- --
Year Ending Mar-14 0 0 0 0
Year Ending Mar-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Wright Reports
$472.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks